These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7599358)

  • 1. Myoblast transfer and gene therapy in muscular dystrophies.
    Pagel CN; Morgan JE
    Microsc Res Tech; 1995 Apr; 30(6):469-79. PubMed ID: 7599358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
    Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
    Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
    Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
    J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell transplantation and gene therapy in muscular dystrophy.
    Morgan JE; Partridge TA
    Bioessays; 1992 Sep; 14(9):641-5. PubMed ID: 1365921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
    Liu F; Nishikawa M; Clemens PR; Huang L
    Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
    Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
    Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
    Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
    J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini- and full-length dystrophin gene transfer induces the recovery of nitric oxide synthase at the sarcolemma of mdx4cv skeletal muscle fibers.
    Decrouy A; Renaud JM; Lunde JA; Dickson G; Jasmin BJ
    Gene Ther; 1998 Jan; 5(1):59-64. PubMed ID: 9536265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy.
    Ohtsuka Y; Udaka K; Yamashiro Y; Yagita H; Okumura K
    J Immunol; 1998 May; 160(9):4635-40. PubMed ID: 9574572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A PCR-based assay for the wild-type dystrophin gene transferred into the mdx mouse.
    Shrager JB; Naji A; Kelly AM; Stedman HH
    Muscle Nerve; 1992 Oct; 15(10):1133-7. PubMed ID: 1357549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases.
    Karpati G; Acsadi G
    Muscle Nerve; 1993 Nov; 16(11):1141-53. PubMed ID: 8413366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses to dystropin: implications for gene therapy of Duchenne muscular dystrophy.
    Ferrer A; Wells KE; Wells DJ
    Gene Ther; 2000 Sep; 7(17):1439-46. PubMed ID: 11001363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of full-length human dystrophin cDNA in mdx mouse muscle by HVJ-liposome injection.
    Yanagihara I; Inui K; Dickson G; Turner G; Piper T; Kaneda Y; Okada S
    Gene Ther; 1996 Jun; 3(6):549-53. PubMed ID: 8789805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs.
    Acsadi G; Dickson G; Love DR; Jani A; Walsh FS; Gurusinghe A; Wolff JA; Davies KE
    Nature; 1991 Aug; 352(6338):815-8. PubMed ID: 1881437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector.
    Bujold M; Caron N; Camiran G; Mukherjee S; Allen PD; Tremblay JP; Wang Y
    Cell Transplant; 2002; 11(8):759-67. PubMed ID: 12588108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Full-length dystrophin gene transfer to the mdx mouse in utero.
    Reay DP; Bilbao R; Koppanati BM; Cai L; O'Day TL; Jiang Z; Zheng H; Watchko JF; Clemens PR
    Gene Ther; 2008 Apr; 15(7):531-6. PubMed ID: 18273052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful transplantation of genetically corrected DMD myoblasts following ex vivo transduction with the dystrophin minigene.
    Moisset PA; Skuk D; Asselin I; Goulet M; Roy B; Karpati G; Tremblay JP
    Biochem Biophys Res Commun; 1998 Jun; 247(1):94-9. PubMed ID: 9636661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene complementation using myoblast transfer into fetal muscle.
    Sopper MM; Hauschka SD; Hoffman E; Ontell M
    Gene Ther; 1994 Mar; 1(2):108-13. PubMed ID: 7584065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.
    Abmayr S; Gregorevic P; Allen JM; Chamberlain JS
    Mol Ther; 2005 Sep; 12(3):441-50. PubMed ID: 16099410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice.
    Yang L; Lochmuller H; Luo J; Massie B; Nalbantoglu J; Karpati G; Petrof BJ
    Gene Ther; 1998 Mar; 5(3):369-79. PubMed ID: 9614557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.